Viewing nowUribix Tablet (Clopidogrel Sulfate)
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
PharmGen Science Co., Ltd.

MFDS item code 201602804 · Approved 2016.05.23 · Insurance code 670104040
Improvement of symptoms of acute coronary syndrome and atherosclerosis; prevention of thromboembolism in atrial fibrillation
This medication is used for adult patients with vascular diseases. It improves symptoms caused by atherosclerosis in patients with ischemic stroke, myocardial infarction, and peripheral artery disease. Additionally, it reduces the risk of cardiovascular complications in patients with acute coronary syndrome. For patients with atrial fibrillation and low bleeding risk, it decreases the risk of stroke and thrombus formation. This medication is effective in enhancing overall vascular health and preventing cardiovascular complications, therefore it is used in the management of atherosclerotic diseases.
1. Patients with ischemic stroke, myocardial infarction, or peripheral arterial disease: Administer clopidogrel 75 mg orally once daily. 2. Patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction): On the day treatment is initiated, start with a loading dose of 300 mg once daily, followed by a maintenance dose of 75 mg once daily orally. Aspirin 75 ~ 325 mg should be administered concomitantly with this medicine once daily. 3. Patients with atrial fibrillation: Administer 75 mg orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly with this medicine once daily. Patients with renal impairment: Treatment experience in patients with renal impairment is limited. Patients with hepatic impairment: Treatment experience in patients with moderate hepatic disease and bleeding diathesis is limited. This medicine may be taken with or without food.
This medication is an anticoagulant that prevents blood clot formation. It needs to be converted into its active form in the liver to be effective; therefore, individuals with genetically decreased enzyme function involved in this activation process may experience diminished drug efficacy. Additionally, concomitant use of drugs that activate certain enzymes may increase blood concentration and elevate bleeding risk, so such combinations should be avoided. Patients allergic to this medication or its components, those already experiencing bleeding, patients with severe liver damage, and nursing mothers should not take this medication. Patients at high risk for bleeding should use this medication cautiously. For instance, if bleeding symptoms occur, immediate medical attention is required, and it may be necessary to discontinue this medication for a period prior to surgery. Furthermore, extra caution is needed when using this medication alongside other bleeding risk medications. During treatment, various adverse reactions such as bleeding, thrombocytopenia, gastrointestinal disturbances, and skin rashes may occur. In particular, bleeding is the most common and significant side effect; thus, any bleeding symptoms must be reported to healthcare personnel immediately. Pregnant or nursing women should consult their physician regarding the effects of this medication on the fetus or newborn and make careful decisions about medication use during breastfeeding. This medication has not been adequately studied for safety and efficacy in children, and its use is not recommended in this population. Elderly individuals may have diminished bodily functions leading to a higher risk of bleeding, thus dosage adjustments and monitoring are necessary during use. Overdose may result in prolonged bleeding times and severe bleeding; currently, there is no antidote for this medication. Treatment for overdose may include platelet transfusions and other supportive measures. This medication should be stored out of reach of children and should not be transferred to other containers.
Bleeding, gastrointestinal bleeding, hospitalization-required bleeding, purpura, contusion, hematoma, nosebleed, hematoma, hematuria, intraocular bleeding, intracranial bleeding, significant bleeding, life-threatening bleeding, fatal bleeding, hemorrhagic stroke, need for anticoagulant use, need for blood transfusion, significant functional impairment, intraocular bleeding accompanied by considerable vision loss, mild bleeding, neutropenia, agranulocytosis, aplastic anemia, thrombocytopenia, abdominal pain, dyspepsia, diarrhea, rash, pruritus, depression, upper respiratory tract infection, shortness of breath, rhinitis, bronchitis, cough, urinary tract infection, chest pain, accidental injury, influenza-like illness, pain, fatigue, edema, hypertension, headache, dizziness, nausea, hypercholesterolemia, arthralgia, low back pain, depression, insomnia, anxiety, anemia, hematochezia, thrombocytopenia, pneumonia, sinusitis, eczema, skin ulcer, cystitis, cataract, conjunctivitis, allergy symptoms, ischemic necrosis, systemic edema, gastritis, hemorrhagic gastroenteritis, duodenal ulcer, gastric ulcer, perforated gastric ulcer, upper gastrointestinal tract ulcer bleeding, distention, hemorrhagic arthropathy, hematuria, hemoptysis, retroperitoneal bleeding, surgical wound bleeding, pulmonary hemorrhage, vasculitis, hypotension, bronchospasm, interstitial pneumonia, eosinophilic pneumonia, colitis, pancreatitis, gastritis, stomatitis, hepatitis, acute hepatic failure, petechial papules, erythematous skin rash, urticaria, itching, angioedema, vesicular dermatitis, drug-induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms, lichen planus, arthritis, myalgia, glomerulopathy, gynecomastia, fever, abnormal liver function test values, increased blood creatinine, cholecystitis, hematemesis, spinal hematoma
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is recommended to store it at room temperature, specifically between 1°C and 30°C.
Pink round film-coated tablet
100 tablets, 30 tablets
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowClopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
PharmGen Science Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Geonil Pharmaceutical Co., Ltd.
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Sama Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Korea Union Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
(Co., Ltd.) Korea Pharma

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.